Short Interest in EUDA Health Holdings Limited (NASDAQ:EUDA) Grows By 1,736.6%

EUDA Health Holdings Limited (NASDAQ:EUDA) saw a significant increase in short interest in April. As of April 30th, there was short interest totaling 87,001 shares, an increase of 1,736.6% from the April 15th total of 4,737 shares. Approximately 3.5% of the shares of the stock are short sold. Based on an average trading volume of 574,255 shares, the short-interest ratio is currently 0.2 days.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Greenridge Global reduced their price objective on shares of EUDA Health from $120.00 to $55.00 and set a “buy” rating for the company in a research note on Monday, March 9th. Weiss Ratings cut shares of EUDA Health from a “sell (d)” rating to a “sell (e+)” rating in a research note on Friday. Finally, Zacks Research raised shares of EUDA Health from a “strong sell” rating to a “hold” rating in a research note on Friday. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, EUDA Health has a consensus rating of “Hold” and an average price target of $55.00.

EUDA Health Stock Up 4.7%

NASDAQ:EUDA opened at $14.40 on Tuesday. The company has a fifty day moving average of $10.50 and a 200 day moving average of $30.94. EUDA Health has a 52 week low of $5.26 and a 52 week high of $86.00. The firm has a market capitalization of $36.29 million, a P/E ratio of -6.00 and a beta of 0.56.

EUDA Health (NASDAQ:EUDA) last posted its quarterly earnings results on Tuesday, May 5th. The company reported ($0.44) EPS for the quarter, beating analysts’ consensus estimates of ($1.20) by $0.76. The firm had revenue of $1.92 million for the quarter, compared to the consensus estimate of $3.90 million. As a group, analysts anticipate that EUDA Health will post 1.6 EPS for the current year.

Institutional Investors Weigh In On EUDA Health

A hedge fund recently bought a new stake in EUDA Health stock. Jane Street Group LLC purchased a new stake in shares of EUDA Health Holdings Limited (NASDAQ:EUDA) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned about 0.07% of EUDA Health as of its most recent SEC filing. 4.35% of the stock is owned by institutional investors and hedge funds.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.